The Hyderabad-based company on Monday announced that it has been selected as a recipient of mRNA technology.
The Hyderabad-based company, Biological E said these capacities will enable it to deliver 300 million doses as promised to the Government of India. Soon, the company plans to deliver more than one billion additional doses globally.
Biological E, the Hyderabad-based vaccine maker, expects the rollout of its Covid-19 vaccine 'Corbevax' by the end of November and is looking to supply nearly 10 crore doses on the day of its launch
Founded in 1953, Biological E claims to be the first private sector biological products company in India.
Pharma major Biological E has sought approval from drug regulator Drugs Controller General of India to conduct the phase-3 clinical trial of Covid vaccine Corbevax.
In a major development, the Government of India has finalised arrangements with Hyderabad-based vaccine manufacturer Biological-E to reserve 30 crore of COVID-19 vaccine doses for the country. As per reports, these vaccine doses will be manufactured and stockpiled by Biological-E from August to December 2021.
Hyderabad: Hyderabad-based vaccines and pharmaceutical company Biological E. Ltd (BE) announced that it has initiated clinical trial of its Covid-19 subunit vaccine candidate in the country on Monday following approval from the Drugs Controller General of India (DGCI). BE collaborated with Dynavax Technologies Corporation (Dynavax), a US-based vaccine focused biopharmaceutical company, and Baylor College of […]
Hyderabad: Envoys of 64 countries on Wednesday visited the facilities of Bharat Biotech and Biological E, which are developing vaccines for coronavirus. After landing in Hyderabad by a special Air India flight, the Ambassadors and High Commissioners from the countries in Asia, Africa, Europe, North America, South America, and Oceania reached Genome Valley on the […]
Copyright © 2024 - Odisha Television Limited All Rights Reserved.